Overview
Drug-interaction Trial in Healthy Subjects With Oral Administration of Empagliflozin (BI 10773), Rifampicin and Probenecid
Status:
Completed
Completed
Trial end date:
2012-08-01
2012-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The objectives of the trial are to investigate the effect of concurrent administration of rifampicin and probenecid on the pharmacokinetics of empagliflozin.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Boehringer IngelheimTreatments:
Empagliflozin
Probenecid
Rifampin
Criteria
Inclusion criteria:1. healthy male and female subjects
Exclusion criteria:
1. any relevant deviation from healthy conditions